NVS
Novartis AG Sponsored ADR · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website novartis.com
- Employees(FY) 101703
- ISIN US66987V1098
Performance
-3.34%
1W
-4.93%
1M
-1.91%
3M
+12.58%
6M
+11.77%
YTD
+19.72%
1Y
Profile
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.
Technical Analysis of NVS 2024-11-01
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-04 12:06
- 2024-11-02 05:38
- 2024-11-01 15:00
- 2024-11-01 09:42
- 2024-11-01 09:32
- 2024-10-31 09:15
- 2024-10-30 15:12
- 2024-10-30 11:49
- 2024-10-30 11:09
- 2024-10-30 11:02
- 2024-10-30 09:40
- 2024-10-30 07:54
Analyst Report: Novartis AG(Yahoo Finance)
- 2024-10-30 07:46
Novartis’ Scemblix gains FDA approval for leukaemia(Pharmaceutical Technology)
- 2024-10-30 07:16
Analyst Report: Novartis AG(Argus Research)
- 2024-10-30 07:01
Market Digest: NVS, BRO, ECL, F, GLW, INCY, TMUS, PFE, PKG, RSG(Argus Research)
- 2024-10-30 06:48
- 2024-10-30 03:07
- 2024-10-29 21:34
- 2024-10-29 17:54
- 2024-10-29 15:03
- 2024-10-29 15:01
Analyst Report: Novartis AG(Morningstar Research)
- 2024-10-29 14:15
Novartis Stock Dives on $800 Million Write-Down(The Wall Street Journal)
- 2024-10-29 13:57
Sector Update: Health Care Stocks Ease Tuesday Afternoon(MT Newswires)
- 2024-10-29 13:00
Novartis Ag (NVS) Q3 2024 Earnings Call Transcript(Motley Fool)
- 2024-10-29 12:13
- 2024-10-29 11:50
- 2024-10-29 11:33
Novartis Sacrifices A Flat Base On Lagging Sales Of Its Biggest Moneymaker(Investor's Business Daily)
- 2024-10-29 10:57
- 2024-10-29 09:30
- 2024-10-29 08:52
Page 1 of 10
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment.